INTRODUCTION
Autosomal dominant optic atrophy (ADOA, MIM165500) is the commonest cause of inherited optic atrophy. Its prevalence is estimated to be between 1/10000 and 1/50000 persons (1, 2) . Clinically, it is characterized by slowly progressive bilateral visual loss with frequent onset within the first two decades, dyschromatopsia, bilateral central scotoma and optic nerve atrophy. ADOA is caused by mutations in the optic atrophy 1 gene (OPA1) (3, 4) , mapped to chromosome 3q28 -q29 and has variable clinical expression and penetrance (5) .
OPA1 comprises 30 exons and is ubiquitously expressed, the highest level in the retina, but also abundantly in brain and muscle (4, 6) . Alternative splicing of exons 4, 4b, 5 and 5b results in at least eight isoforms, whose tissue distribution and relative abundance are scarcely known (7) . Common to all isoforms of Opa1 are a GTPase, dynamin-like domain; a central domain; a C-terminal coiled coil domain presumably involved in protein -protein interaction; and an N-terminal mitochondrial targeting sequence that directs the protein to the inner mitochondrial membrane, facing the intermembrane space (8) . Proteolytic cleavage of Opa1 occurs through distinct molecular pathways, both constitutively in a subset of Opa1 isoforms, and also by induction of apoptosis or loss of the mitochondrial membrane potential leading to Opa1 inactivation and mitochondrial fragmentation (9) .
Various pathogenic mutations are dispersed throughout the gene coding sequence, but most occur in the catalytic GTPase domain (10) . Almost 50% lead to premature truncation of the protein, and probably haploinsufficiency.
'ADOA plus' are rare complicated phenotypes with encephalomyopathic presentations, including sensorineural deafness (11) , ataxia, ophthalmoplegia (12) (13) (14) , peripheral neuropathy, associated with missense mutations in the GTPase domain through a possible semi-dominant mechanism. To date, only in these ADOA plus families, multiple mtDNA deletions were observed, which might explain defective energy metabolism and contribute to the atypical multisystemic phenotype.
OPA1 has been linked to two important mitochondrial activities: fusion (15) , that in equilibrium with fission regulates mitochondrial morphology (16) , and caspase-dependent apoptosis through mitochondrial cristae remodeling (17, 18) . The equilibrium between mitochondrial fusion and fission appears very dynamic and links mitochondrial morphology to mitochondrial function (16) and vice versa. Recent reports have also associated common OPA1 mutations, predicted to generate a truncated OPA1 protein and typical of uncomplicated ADOA phenotypes, to impaired oxidative phosphorylation with mitochondrial fragmentation in fibroblasts, and increased susceptibility to apoptosis (19, 20) . Moreover, the association of multiple mtDNA deletions with 'ADOA plus' phenotypes and missense mutations has suggested a putative role of OPA1 in mtDNA integrity maintenance (14) . However, the relative contribution of these mechanisms to uncomplicated ADOA pathogenesis as well as their mutual relationships has not been unraveled. Thus, several important questions remain unanswered: is the mitochondrial fragmentation observed in OPA1-mutant cells a cause or a consequence of altered bioenergetics and apoptosis? Is pathology of ADOA really restricted to the optic nerve? What is the cause of the apparently exclusive susceptibility of the retinal ganglion cell (RGC) in ADOA, given that OPA1 is ubiquitously expressed?
In order to address the above questions, we investigated possible signs of neuromuscular involvement in a family with a non-syndromic form of ADOA harboring a novel OPA1 deletion. We then addressed its effects on mitochondrial function, morphology and viability in ex vivo biopsies.
RESULTS
A novel mutation in the Opa1 GTPase domain associated with extraocular signs All patients were females of one family (Fig. 1A) . The proband, Patient III-4 (47-year-old) developed chronic progressive visual loss from age 7, impaired color discrimination and later nocturnal distal paresthesias of the four limbs (Table 1) . Neurological examination showed bilateral optic disc pallor (Fig. 1B) and pes cavus. Increased creatine kinase levels (208 U/L, nv 0-160) and neutropenia were found. Electromyography (EMG) showed a decrease in compound motor and sensory action potentials, slightly reduced conduction velocities in the lower extremities (sural nerve sensory conduction velocities 38 m/s) and initial denervation signs at the tibialis anterioris bilaterally indicating a moderate-severe predominantly axonal sensorymotor peripheral neuropathy at the lower extremities. Her father, affected by progressive visual loss, had gait difficulties in his old age. The 22-year-old daughter presented progressive visual loss from childhood, and type-I diabetes.
Patient III-6 (46-year-old) had chronic progressive visual loss from age 13. Neurological examination revealed bilateral optic disk pallor, moderate muscle deficit at the right tibialis anterioris and winging scapulae. EMG disclosed mild decrease of motor and sensory conduction velocities in the lower extremities and increased distal latencies, indicating a predominantly demyelinating peripheral neuropathy at the lower extremities.
Patient III-8 (44-year-old) presented chronic progressive visual loss from age 13. Neurological examination showed global optic disk pallor and winging scapulae. EMG was normal.
Brain MRI showed bilateral postlaminar optic nerve atrophy in all three patients (Fig. 1C) . Audiometry was normal in all, as were lactate and pyruvate blood levels.
The clinical presentation of the patients, affected by prominent bilateral chronic progressive optic atrophy with childhood-onset, in association with a genetic inheritance consistent with an autosomal dominant pattern, prompted us to perform molecular analysis of the OPA1 gene.
Complete sequencing of OPA1 demonstrated a new 38-base-pair deletion (c1410_1443þ4del38) spanning exon and intron 14 in the catalytic GTPase domain, with a predicted splice-site defect.
Expression of OPA1 c1410_144314del38
The mutation abolishes the physiological splice site at the 3 0 -end of exon 14. Amplification of cDNA extracted from patient fibroblasts revealed the presence of five different transcripts ( Fig. 2A) , one produced by the wild-type allele, the others resulting from the activation of cryptic splice sites in exon 14 or intron 14. The most abundant transcript results from the activation of a cryptic site 54 nucleotides downstream from the intron -exon boundary. It encodes for a truncated protein through the presence of an in-frame UAA termination signal in the retained intronic sequence, 11 codons after the deletion breakpoint, with a predicted protein product of 481 amino acids ( Fig. 2A) , undetectable by commercial antibodies targeted to epitopes between amino acid residue 500 and the C terminal. The three shorter transcripts, which are much less abundant, are produced by cryptic sites in intron 14 (five nucleotides after the intron-exon boundary), or in exon 14, 39 or 90 nucleotides upstream of the intronexon boundary. These three transcripts maintain the correct reading frame, and are predicted to produce proteins lacking 11, 13 or 30 amino acids within the GTPase domain
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( Fig. 2A) . It is not clear if these polypeptides are stable; however, it should be noted that the longest transcript accounts for the vast majority of aberrant transcripts seen in patient fibroblasts (.75% on densitometric analysis). Consistent with the molecular data is the abundance of full-length Opa1 protein in patient fibroblasts obtained by immunoblotting (47% of controls) (Fig. 2B ).
Skeletal muscle abnormalities in OPA1 c1410_144314del38 patients
In order to investigate neuromuscular effects caused by OPA1 gene mutation, skeletal muscle biopsies were performed.
Immunoblotting indicated a significant decrease of Opa1 (31%) compared to controls (Fig. 3I) . Morphological muscle analysis revealed mild abnormalities associated with denervation, e.g. atrophic type-I and -II fibers, angulated fibers, small-type grouping at ATPase staining and also some ring-shaped, split fibers (Fig. 3A) . Muscle fibers had abnormal oxidative stain reactions with irregular central areas of loss of staining and subsarcolemmal and intermyofibrillar aggregates ( Fig. 3B-D) . Ragged red fibers or COX-negative fibers typical of mitochondrial DNA diseases were absent. However, ultrastructural analysis showed subsarcolemmal and intermyofibrillar aggregates of mitochondria with increased size variability, electron dense matrix (Fig. 3E-F ). There were focal cristae abnormalities represented by tubulo-vescicular cristae and concentric abnormalities (Fig. 3G) . Crystalline or paracrystalline inclusions were absent. Additionally, in Patient I, we observed myofibrillar disarray and lysis, and some atrophic and degenerated fibers with pycnotic nuclei and lipid droplets. OXPHOS activities were normal and both mitochondrial mass, expressed as citrate synthase activity, and mitochondrial DNA content, expressed as ratio cytB to Amyloid Precursor protein genes, were similar in ADOA compared to controls (58.29 + 6.12 nmol/min/mg versus 63.88 + 8.01; 1.65 + 0.66 A.U. versus 1.76 + 0.51, respectively). Southern blot analysis of mtDNA to screen for the presence of large-scale rearrangements was negative (Fig. 3H ). In conclusion, these results showed that a decrease of Opa1 resulted in muscular atrophy and altered mitochondrial morphology, but not overt impairment of the respiratory chain or mtDNA instability.
Prominent mitochondrial morphology and distribution defects in cells derived from OPA1 c1410_144314del38 patients
To address the relative contribution of mitochondrial dysfunction versus morphological derangement in the observed muscular defects, we used primary cultures of fibroblasts and C). Aberrant mitochondrial shape was also retrieved in differentiated myotubes. Mitochondria of control myotubes displayed a tubular morphology with homogeneous reticular distribution along the whole cell (Fig. 4D ). In ADOA myotubes, areas of tubular mitochondria alternated with areas of fragmented mitochondria even within the same cell, sometimes with a 'beads on a string' pattern ( Fig. 4E) or abnormal large spherical morphology. Moreover, spatial distribution of mitochondria was remarkably irregular in ADOA myotubes, with areas of abnormal mitochondrial clustering while other areas were almost completely devoid of mitochondria ( Fig. 4F -H) . The visual appearance of altered mitochondrial distribution was corroborated by quantitative analysis calculated as parameter R, based on the ratio between average and maximal fluorescence on a given cell (examples are shown in Fig. 4H-I ). This parameter was significantly decreased in OPA1 mutant myotubes compared to controls (R ¼ 0.19 + 0.01, n ¼ 18 versus 0.41 + 0.03, n ¼ 17 in controls; P , 0.0001) (Fig. 4J ) reflecting relatively lower average fluorescence intensity in areas of mitochondrial dearth and higher fluorescence values in areas of mitochondrial aggregation. Thus, our data indicate that mutated OPA1 results in abnormal mitochondrial shape and distribution under basal conditions.
Bioenergetics, ROS production and response to apoptotic stimuli are not impaired in cells derived from OPA1 c1410_144314del38 patients
Defects in mitochondrial morphology are often ancillary to primary impairment of mitochondrial function. To verify whether the observed organelle shape changes were a primary consequence of loss of pro-fusion activity of OPA1, we performed a functional analysis of the fibroblasts and myotubes isolated from the patients. Preserved functions of both respiratory chain and ATP synthase, and integrity of the inner mitochondrial membrane were confirmed by evaluating the DC m of the fibroblasts under both state 3 and 4 respirations, and by measuring their ATP synthesis rate.
DC m was measured in resting fibroblasts cultured under different metabolic conditions: in glucose/pyruvate medium (data not shown) and in galactose/pyruvate medium ( Fig. 5A -C) where galactose substituted for glucose as a substrate to push the aerobic mitochondrial ATP production. Though the ADOA cells show a slightly increased DC m compared to controls, the difference is below statistical significance both when ATP is actively synthesized (state 3) and when the ATP synthase proton channel is blocked by oligomycin (condition mimicking state 4) (Fig. 5B-C) . We also evaluated DC m under state 3 and 4 conditions by TMRM probe using fluorescence microscopy, but no significant difference was observed in any tested culture condition between patients (Fig. 5B2 and C2 ) and controls ( Fig. 5B1  and C1 ). The complex I-driven ATP synthesis rate was measured in resting fibroblasts cultured under different metabolic conditions, including the two above ( Fig. 5D -E) and in galactose/pyruvate medium containing gramicidin to induce high energy demand (Fig. 5F ). Gramicidin is an ionophore that stimulates ATP hydrolysis by the plasma membrane Na þ /K þ -ATPase. Our analysis indicates that the more energy is produced by OXPHOS, the more ATP synthesis rate falls in the ADOA compared to controls, but in none of the tested conditions was statistical significance reached, and the maximum , (E) and (F) show the complex I-driven ATP synthesis rate measured in fibroblasts of both controls and ADOA patients cultured in 25 mM glucose-110 mg/l pyruvate medium, 5 mM galactose-110 mg/l pyruvate medium and 5 mM galactose-110 mg/l pyruvateþ40 ng/ml gramicidin medium, respectively. The mitochondrial ATP synthesis reaction was induced adding to digitonin-permeabilized fibroblasts (3 Â 10 6 cells/ml) 10 mM glutamate/10 mM malate and 0.5 mM ADP. The data are averages + SD of two independent triplicate experiments.
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difference between the two sets of samples was below 20% (Fig. 5E-F) . To assess the energy availability of ADOA fibroblasts maintained in galactose/pyruvate medium, we determined the cellular ATP content (30 nmol/mg protein), which was similar to controls (data not shown). Latent mitochondrial dysfunction can be revealed by the real-time analysis of the changes in mitochondrial membrane potential following administration of ATPase inhibitor oligomycin. In cells where membrane potential is maintained by the reversal function of the ATPase, oligomycin causes a drop in TMRM fluorescence as opposed to the expected increase that follows inhibition of ATP synthesis in healthy mitochondria (21) . Notably, in both control and patients' fibroblasts and myotubes, oligomycin resulted in an increase in mitochondrial TMRM fluorescence, indicating that membrane potential is maintained by proton pumping of fully functional respiratory chain complexes (Fig. 6A) . Similarly, analysis of superoxide and H 2 O 2 generation, detected by the fluorescence of the mitochondrially targeted MitoSOX (Supplementary Material, Fig. S1 ), and of the indicator Amplex Red (Fig. 6B) , respectively, showed no difference between the two samples, indicating that the production of both ROS species, which often follows mitochondrial respiratory defects, was not increased in ADOA cells.
Finally, we verified if the abnormal mitochondrial network might be the result of a pre-apoptotic state, or lead to increased sensitivity to apoptosis, by testing fibroblast response to three different intrinsic apoptotic stimuli: etoposide, staurosporine and H 2 O 2 . A small, but not statistically significant increase in death was observed in ADOA fibroblasts both before and after administration of the apoptotic stimuli (Fig. 6C) indicating that at least the endpoint of apoptosis was unaffected by this ADOA mutation.
DISCUSSION
We report an ADOA family with a novel OPA1 gene deletion affecting the GTPase domain. Interestingly, we found subclinical neuromuscular involvement in addition to optic neuropathy, the cardinal feature of ADOA. These results were not unexpected considering the ubiquitous expression of OPA1, more prominent in the RGC but still considerable in skeletal muscle, brain and other tissues (4). Of note, skeletal muscle did not carry mtDNA deletions, suggesting no mtDNA instability. Overall, these data indicate that ADOA might have a predominant but not exclusive tropism for the optic nerves, and that neuromuscular abnormalities might be underestimated in classical ADOA and should be evaluated also in patients with different mutations.
The contribution of impaired OXPHOS and perturbed mitochondrial network to uncomplicated ADOA was uncertain. Our data show that mitochondrial network disruption is sufficient to cause ADOA without any appreciable respiratory deficiency.
Extensive bioenergetic evaluation did not detect any defect in ADOA fibroblasts even under stressed metabolic conditions, or in differentiated myotubes. These results differ from data recently reported by Zanna et al. (19) showing decreased complex I-driven ATP synthesis in ADOAfibroblasts grown in glucose-free medium. However, this is in contrast with the reported normal cellular ATP content and cell growth that should indicate the absence of significant energetic defects. Moreover, being the mitochondrial mass of mutant cells grown in glucose-free medium 20% higher than controls (19) , the reduction of the ATP synthesis rate evaluated as ATP synthesis/CS ratio, results in an overestimation of the possible cellular energetic defect. We propose that energy defect could variably arise to different extents from different mutations of the OPA1 gene, being more severe with missense mutations that determine 'ADOA plus' multisystemic phenotypes (11, 13, 14) with mtDNA multiple deletions, ragged red and cox-negative fibers, typical of classical mtDNA mitochondriopathies. However, bioenergetic failure alone would not explain why the high energy dependent pigmented epithelium of the retina and other types of neurons are not affected in the uncomplicated presentation of ADOA despite significant expression levels of Opa1 (6) . In fact, pigmentary retinopathy, not observed in ADOA, occurs frequently in mitochondrial diseases with compromised energy metabolism (22) and severe complex-I deficiency associated with Leigh syndrome encephalo-cardiomyopathy is not necessarily associated with optic atrophy, even when caused by mutations in housekeeping genes in the nuclear DNA (23, 24) .
Moreover, while a putative pathogenetic analogy with Leber's hereditary optic neuropathy (LHON), associated with mtDNA mutations affecting complex I-subunits, would seem attractive, significant clinical and biochemical differences between the two conditions make this comparison unsatisfactory. In fact, while the end-stages of the two conditions are similar, ADOA gives a bilateral, slowly progressive visual loss in childhood, in contrast with LHON which is characterized by a later subacute and monolateral onset.
Moreover, in contrast with our data, LHON shows normal or slightly reduced redox activities of complex I (25), but induces severe complex I-driven ATP synthesis, impaired growth in galactose medium and ROS overproduction (26, 27) . In summary, inadequate energy production does not provide a comprehensive and simplistic explanation for ADOA pathogenesis nor for its predominant RGC involvement.
In contrast, we found a collapse of the mitochondrial network in ADOA fibroblasts and myotubes carrying an OPA1 deletion even under basal conditions in glucose medium, indicating that abnormal mitochondrial shape and distribution could be relevant per se in ADOA pathogenesis and in the relative tissue selectivity of the RGCs, as previously hypothesized (28, 29) . In contrast, in a previous study (19) , mitochondrial fragmentation was observed in OPA1-haploinsufficient fibroblasts only under stressed metabolic conditions forcing oxidative phosphorylation, being possibly interpreted as a consequence of their defective complex I activity.
Moreover, we have provided, for the first time, data of mitochondrial architecture in differentiated OPA1-mutant myotubes: there were areas of mitochondrial clustering interposed with areas presenting very low mitochondrial density. The effect of OPA1 mutation on mitochondrial distribution seems to have some cell-type specificity, since it was evident in differentiated myotubes, rather than in fibroblasts. This may depend on relative Opa1 abundance and/or isoform expression, and different complexity of the mitochondrial network in different cell types.
Because of its unique ultrastructural and functional peculiarities, mitochondrial distribution is strictly regulated in the optic nerve to provide calibrated energy supply depending on different regional energy requirements. Mitochondrial concentration is, therefore, higher in the prelaminar unmyelinated optic nerve fibers, internodal regions and synapses where ATP consumption is higher and density of voltage-gated sodium channels is greater (30) . Conversely, it is lower in the post-laminar myelinated region where energy requirement is reduced. This heterogeneous distribution is actively maintained to support normal function (28) . As mitochondrial dynamics is crucial in providing the necessary energy at the right time and place (31), it is conceivable that the altered dynamics resulting from OPA1 mutation could trigger more pathological consequences in the RGCs than in other cell types.
Similar alterations in the architecture of the mitochondrial network were observed in OPA1 silenced rat RGCs (32), as well as COS-7 cells expressing OPA1 gene mutants (33) , and patient's monocytes (3). However, the interpretation had been limited by lack of parallel mitochondrial functional analysis to rule out perturbed bioenergetics or apoptosis as the causes of these structural changes.
Moreover, abnormal mitochondrial distribution had also been observed in cell models of various neurodegenerative conditions, such as MFN2 mutant neurons (34) , and myotubes (35) , as well as in peripheral nerves of Charcot-Marie Tooth 2A (CMT2A) patients (36) , and in optic nerves of patients affected by LHON (37) .
Interestingly, MFN2, such as OPA1, is a dynamin-related GTPase involved in mitochondrial fusion. MFN2 mutations give rise to CMT2A, characterized by severe axonal peripheral neuropathy, sometimes with subacute optic neuropathy (38) . An interesting speculation might be that the partial clinical overlap is caused by partial functional homologies between the two fusion proteins.
Finally, rearrangements of the mitochondrial distribution have also been related to increased ROS formation or apoptosis (39) . However, in our experiments, mitochondrial network disruption was not associated with increased ROS production or significant vulnerability to pro-apoptotic stimuli, in contrast with a previous study (20) .
We, therefore, suggest that abnormal mitochondrial network is the primary defect, at least in this pedigree of ADOA patients, whereas different mutation types could be associated with different bioenergetic profiles and susceptibility to apoptosis. An imbalance between the topographically different energy requirements of the RGCs and the supply of energy provided by mislocated mitochondria could lead to subcellular energy depletion and eventually progressive axonal impairment and cell death. In addition, the pathological fragmentation of the mitochondrial network could also lead to impaired calcium metabolism, abnormal electro-chemical connection between mitochondria and mtDNA complementation defects in susceptible cells (e.g. postmitotic) increasing interorganellar functional heterogeneity (40) .
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Biochemical effects might vary according to different OPA1 mutations, but also to the different tissues examined, owing to their specific histological organization, cell metabolism and expression of different OPA1 isoforms. Therefore, we suggest that extensive multiparametric mitochondrial analysis in different ADOA pedigrees should be not restricted to fibroblasts but extended to different cell types, and detailed neuropathological examinations of patients will be crucial in finding a common denominator of the pleiotropic effects of OPA1-mutants as the main pathogenetic mechanism.
Finally, these findings raise questions about the mechanism behind the mitochondrial spatial abnormalities in ADOA. It is now clear that the relocation of mitochondria requires competent fusion and fission machineries, as observed in leukocytes (41) and in neurons (42) . One might speculate that mitochondrial clusters could result in OPA1-mutated cells from partially impaired fusion due to unopposed fission or from intermitochondrial tethering, as found in cells expressing truncated mitofusin-1 (43) . Dissection of the biological machinery underlying altered mitochondrial dynamics and its functional consequences in differentiated cells is likely to have a relevant impact in understanding a number of neurodegenerative diseases.
MATERIAL AND METHODS

Genetic analysis
After informed consent, genomic DNA was obtained using standard extraction protocols. OPA1 gene analysis was performed by PCR DNA amplification, DHPLC and direct DNA sequencing as described (44) .
Analysis of mRNA splicing in fibroblasts
Total RNA was extracted from primary cultured skin fibroblasts of patients using Trizol (Invitrogen) according to the manufacturer's protocol. cDNA was synthesized using superscript III reverse transcriptase (Invitrogen) and random hexameres. A fragment encompassing the exons 13, 14 and 15 was amplified using primers 5 0 -TGCAGAATCCTAATGCC ATC-3 0 and 5 0 -GAGCTGTTCCCTTTTCCTGT-3 0 and Taq DNA polymerase (Roche) and 5% DMSO. PCR conditions were 948C 3 min, 35 cycles of 948C 1 min, 558C 1 min and 728C 1 min, and a final extension step of 728C for 7 min. PCR products were separated on a 4% agarose gel, excised and sequenced using amplification primers and the Big Dye Ready reaction kit and the 310 Genetic Analyzer (Applied Biosystems).
Muscle tissue analysis
Samples of skeletal muscle biopsies, stored at 2808C, were used for morphological, biochemical and immunoblotting analysis. Electron microscopy analysis was performed on fixed muscle specimens as described (45) . The activities of NADH dehydrogenase (C-I), succinate dehydrogenase (C-II), NADH-cytochrome c oxidoreductase (C-I/III), SDHcytochrome c oxireductase (C-II/III), cytochrome c oxidase (C-IV) and citrate synthase were measured in 600 g supernatant of tissue homogenates as described elsewhere (46) .
Homogenates of muscle biopsies were analyzed by western blotting using mouse anti-Opa1 antibody raised against the amino acid residues 708 -830 (BD Transduction Laboratories) and visualized by ECL (Amersham). Protein quantity was determined by densitometry and normalized by the actin band.
MtDNA was quantified by RT -PCR as described (47) . Total DNA samples were obtained from muscle tissue of three patients and four controls. DNA extraction was performed using GenElute TM Mammalian Genomic DNA Miniprep Kit (Sigma, USA).
The mtDNA copy number was estimated by amplifying a portion of the cytochrome b (cyt b) gene of mtDNA and comparing it to the amplification profile of a nuclear single copy gene, Amyloid Precursor protein (APP). Primers for cyt b were: forward 5 0 -GCC TGC CTG ATC CTC CAA AT-3 0 , reverse 5 0 -AAG GTA GCG GAT GAT TCA GCC-3 0 . Primers for APP were: forward 5 0 -TTT TTG TGT GCT CTC CCA GGT CT-3 0 , reverse 5 0 -TGG TCA CTG GTT GGT TGG C-3 0 . ABI PRISM 7000 Sequence Detection System and Platinum SYBR green qPCR SuperMix-UDG (Invitrogen, USA) were used.
Southern blot analysis was carried out on PvuII digested total DNA using a non-radioactive hybridization system based on direct labeling of probe with horseradish peroxidase and detection system based on chemiluminescence (ECL Direct Nucleic Acid Labeling and Detection System RPN3000 GE Healthcare Amersham). Ten micrograms of genomic DNA extracted from muscle tissue with standard methods were southern blotted as described (48) . Overnight hybridization was carried out following the protocol of the ECL Kit, using, as probes, two different PCR fragments of mtDNA. All procedures were performed following the ECL Kit instructions. Chemiluminescent reaction was carried out on the filter, which was then immediately used for autoradiography on Hyperfilm ECL Amersham (RPN3103K).
Mitochondrial morphology and distribution in cultured cells
Primary fibroblasts cultures were obtained from two patients (patient III-4, III-6) and three adult controls as described (49) . The experiments were performed on cells with similar passage numbers 3 to 15. Myoblast cultures were obtained from muscle biopsies of ADOA patients and controls, and differentiated as previously described (49) . Mitochondrial morphology was assayed in: (i) fibroblasts transfected with plasmids for expression of mitochondrially targeted DsRed (mtRFP) using Lipofectamine (Invitrogen); (ii) myotubes grown on coverslips loaded with 125 nM MitoTracker Red (Molecular Probes) in growth medium for 30' at 378C, and observed in Hanks Buffered Salt Solution (HBSS). Fluorescence images were captured on living cells using a confocal Leica TCF SP5 microscope. For morphological quantification, fibroblasts were classified into two categories based on appearance of their mitochondrial network: (i) fragmentedintermediate length mitochondria when they predominantly appeared as spheres (,2 mm) or very short rods (,5 mm); (ii) tubular mitochondria when they appeared as elongated cables (.5 mm).
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Analysis of mitochondrial subcellular distribution
We defined a distribution parameter R, independent of variability of MitoTraker Red loading and fluorescence emission intensity in relation to myotube position along the z-axis within cell layers. For a given region of interest (ROI) of the myotube, the distribution parameter was defined as R;F/F max , where F is mean fluorescence of the ROI (background subtracted image) and F max its highest fluorescence value. Images with saturated F max values were excluded from the analysis. For each myotube, the ROI was drawn with comparable area, based on the contours identified in bright-field (Fig. 4H) . R (between 0 and 1) is expected to have higher values in cells with homogeneous mitochondrial distribution, as F is closer to F max compared to cells displaying mitochondrial clustering (Fig. 4I) . Using the ratio F to F max helps to eliminate errors due to variability in fluorescence intensity.
Bioenergetic analysis in cultured cells
Mitochondrial membrane potential (DC m ) response to oligomycin. Fibroblasts and myotubes were loaded with 20 nM tetramethyl rhodamine methyl ester (TMRM), a potentiometric fluorescent probe. Changes in TMRM fluorescence were monitored as described (21) .
DC m measurement. Fluorescence micrographs of oligomycintreated (state 4 respiratory condition) and untreated (state 3) adherent permeabilized fibroblasts were obtained as reported (50) . Images were acquired using a fluorescence inverted microscope (Olympus IX50 equipped with a color CCD camera). Multiple high-power (20Â) images were acquired with IAS2000 software (Delta Sistemi, Italy). To quantitate DC m under different metabolic conditions, steady-state fluorescence quenching measurements of permeabilized cells incubated with rhodamine 123 (RH-123) were carried out as described (50, 51) .
ATP synthesis. Mitochondrial ATP synthase activity was determined in permeabilized fibroblasts as described (52) .
Citrate synthase. Citrate synthase activity was assayed according to Trounce's method (53) . The cell sample protein concentration was quantified as described (52) .
ROS determination
The selective detection of superoxide in the mitochondria of fibroblasts was obtained using MitoSOX Red (Molecular Probe) (54) . Fibroblasts, grown on cover glass, were allowed to load MitoSOX for 20 min at 378C at final concentration of 0.25 mM in HBSS. Before analysis with inverted microscope (Ex:510-Em:560), the fluorescent probe was washed out and cells were kept 20 min in incubator at 378C. To test if the fluorescence was effectively produced by superoxide, cells were pre-incubated overnight with 0.5 mM N-acetyl cysteine and for 30 min with 0.1 mM Trolox. The fluorescent signal was abolished by 5 min pre-treatment with 20 mM FCCP. Rate of mitochondrial superoxide production, expressed in arbitrary units (AU)/hour/10 6 cells, was carried out by flow cytometry (FACS Calibur) using cells loaded in the same way with MitoSOX. The average intensity of MitoSOX fluorescence was recorded at time 0 and 10 min. The rate of H 2 O 2 formation in living fibroblasts and myotubes was determined using the oxidation in the extracellular medium of 20 mM fluorogenic indicator Amplex Red (Invitrogen) in presence of 1 unit/ml horseradish peroxidase (Sigma) as described (55) .
Analysis of cell death
A total of 3 Â 10 5 fibroblasts of the indicated genotype were incubated for 24 h with 10 mM etoposide (Sigma), 300 mM H 2 O 2 , 750 nM staurosporine (Sigma) and stained with Annexin-V-Fluos (Boeringher) and propidium iodide, according to manufacturer's protocol. Apoptosis was measured by flow cytometry (FACS Calibur) as percentage of Annexin-V-positive events.
Statistical analysis
Data were expressed as mean + SE or SD as indicated. Statistical analysis of group differences was performed using the Student t-test. Differences were considered significant at 95% confidence level (P , 0.05). Where appropriate, one-way ANOVA was applied with multiple comparisons followed by Bonferroni post hoc test.
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